Bonus Biogroup Stock Analysis
| BBIXF Stock | USD 0.05 0.00 0.00% |
Bonus BioGroup is overvalued with Real Value of 0.0425 and Hype Value of 0.05. The main objective of Bonus BioGroup pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bonus BioGroup is worth, separate from its market price. There are two main types of Bonus BioGroup's stock analysis: fundamental analysis and technical analysis.
The Bonus BioGroup pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bonus BioGroup's ongoing operational relationships across important fundamental and technical indicators.
Bonus |
Bonus Pink Sheet Analysis Notes
About 50.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel. Bonus Biogroup is traded on OTC Exchange in the United States.The quote for Bonus BioGroup is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bonus BioGroup please contact Shai Meretzki at 972 7 320 67104 or go to https://www.bonusbiogroup.com.Bonus BioGroup Investment Alerts
| Bonus BioGroup is way too risky over 90 days horizon | |
| Bonus BioGroup has some characteristics of a very speculative penny stock | |
| Bonus BioGroup appears to be risky and price may revert if volatility continues | |
| Bonus BioGroup has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (90.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bonus BioGroup generates negative cash flow from operations | |
| About 50.0% of the company shares are held by company insiders |
Bonus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 62.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bonus BioGroup's market, we take the total number of its shares issued and multiply it by Bonus BioGroup's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 2nd of March, Bonus BioGroup shows the Risk Adjusted Performance of 0.1324, mean deviation of 3.91, and Standard Deviation of 10.9. Bonus BioGroup technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bonus BioGroup variance and skewness to decide if Bonus BioGroup is priced correctly, providing market reflects its regular price of 0.05 per share. As Bonus BioGroup appears to be a penny stock we also recommend to validate its information ratio numbers.Bonus BioGroup Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bonus BioGroup middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bonus BioGroup. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bonus BioGroup Predictive Daily Indicators
Bonus BioGroup intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bonus BioGroup pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Bonus BioGroup Forecast Models
Bonus BioGroup's time-series forecasting models are one of many Bonus BioGroup's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bonus BioGroup's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bonus Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bonus BioGroup prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bonus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bonus BioGroup. By using and applying Bonus Pink Sheet analysis, traders can create a robust methodology for identifying Bonus entry and exit points for their positions.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel. Bonus Biogroup is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bonus BioGroup to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for Bonus Pink Sheet analysis
When running Bonus BioGroup's price analysis, check to measure Bonus BioGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus BioGroup is operating at the current time. Most of Bonus BioGroup's value examination focuses on studying past and present price action to predict the probability of Bonus BioGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus BioGroup's price. Additionally, you may evaluate how the addition of Bonus BioGroup to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |